Sex differences exist in the depressive disorder prevalence and response to treatment. Several studies suggest that females respond better than males to the action of selective serotonin reuptake inhibitors (SSRIs), suggesting that gonadal hormones modulate mood and the response to these drugs. Sexual steroid hormones exert organizational actions (perennial and on early development) and activational effects (transient and on differentiated tissues). The aim of this study was to analyze sex differences in the forced swim test (FST) in animals without treatment and after fluoxetine (FLX, 0, 2.5, 5.0 and 10.0 mg/kg). Initially, we compared male and female adult rats under control conditions or after altering their sexual differentiation process (at day 5 postnatally, PN, 60 lg of testosterone propionate to females and male castration to induce or preclude masculinization, respectively). To further analyze if the sex differences depend on organizational or activational steroid hormone action we tested the same animals before and after adult gonadectomy. To prevent variations depending upon the estrous cycle, control and masculinized females were tested in estrus. Control females showed lower immobility and required lower doses of FLX (5 mg/kg), to show an antide-pressant-like effect, than males (10 mg/kg), even after adult gonadectomy. In control males adult orchidectomy prevented FLX's action. Neonatally masculinized females exhibited analogous levels of immobility than control ones; before ovariectomy they responded to FLX similar to controls, but after the surgery they did not respond to fluoxetine. Neonatally orchidectomized males exhibited similar immobility values and response to FLX than control pair depends on the hormones organizational effects and, in males, the response to FLX relies on organizational and activational actions. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.
[2]
American Psychiatric Association [APA], 2000, DIAGNOSTIC STAT MANU, VVolume 1, P943, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]
机构:
Fed Fac Med Sci Porto Alegre, Div Pharmacol, BR-9005070 Porto Alegre, RS, BrazilFed Fac Med Sci Porto Alegre, Div Pharmacol, BR-9005070 Porto Alegre, RS, Brazil
Barros, HMT
Ferigolo, M
论文数: 0引用数: 0
h-index: 0
机构:
Fed Fac Med Sci Porto Alegre, Div Pharmacol, BR-9005070 Porto Alegre, RS, BrazilFed Fac Med Sci Porto Alegre, Div Pharmacol, BR-9005070 Porto Alegre, RS, Brazil
机构:
Inst Nacl Psiquiatria Ramon Fuente, Clin Res Subdirect, Mexico City, DF, MexicoInst Nacl Psiquiatria Ramon Fuente, Clin Res Subdirect, Mexico City, DF, Mexico
Berlanga, Carlos
Flores-Ramos, Monica
论文数: 0引用数: 0
h-index: 0
机构:
Inst Nacl Psiquiatria Ramon Fuente, Clin Res Subdirect, Mexico City, DF, MexicoInst Nacl Psiquiatria Ramon Fuente, Clin Res Subdirect, Mexico City, DF, Mexico
[2]
American Psychiatric Association [APA], 2000, DIAGNOSTIC STAT MANU, VVolume 1, P943, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]
机构:
Fed Fac Med Sci Porto Alegre, Div Pharmacol, BR-9005070 Porto Alegre, RS, BrazilFed Fac Med Sci Porto Alegre, Div Pharmacol, BR-9005070 Porto Alegre, RS, Brazil
Barros, HMT
Ferigolo, M
论文数: 0引用数: 0
h-index: 0
机构:
Fed Fac Med Sci Porto Alegre, Div Pharmacol, BR-9005070 Porto Alegre, RS, BrazilFed Fac Med Sci Porto Alegre, Div Pharmacol, BR-9005070 Porto Alegre, RS, Brazil
机构:
Inst Nacl Psiquiatria Ramon Fuente, Clin Res Subdirect, Mexico City, DF, MexicoInst Nacl Psiquiatria Ramon Fuente, Clin Res Subdirect, Mexico City, DF, Mexico
Berlanga, Carlos
Flores-Ramos, Monica
论文数: 0引用数: 0
h-index: 0
机构:
Inst Nacl Psiquiatria Ramon Fuente, Clin Res Subdirect, Mexico City, DF, MexicoInst Nacl Psiquiatria Ramon Fuente, Clin Res Subdirect, Mexico City, DF, Mexico